This latter study supports the idea that MKPs might either suppress or promote carcinogenesis depending on the oncogenic and tissue context (Fig. 4, Table 4) and it will be interesting to see the results of DUSP5 ablation in other, more clinically relevant, murine models of Ras- and Braf-driven cancer. This evidence concerns the gene BRAF and cancer.